ATC level 4
J05AGDirect acting antiviral, subgroup J05AG
- Molecules
- 5
- Subgroups
- 5
ATC J05AG (Direct acting antiviral, subgroup J05AG) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 5 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under J05AG.
- DoravirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor1 presentation1 brandJ05AG06
- EfavirenzHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor4 presentations1 brandJ05AG03
- EtravirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor6 presentations2 brandsJ05AG04
- NevirapineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor3 presentations1 brandJ05AG01
- RilpivirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor3 presentations3 brandsJ05AG05
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.